FDA Approves Genentech’s Lucentis (ranibizumab injection) 0.3 mg Prefilled Syringe for Diabetic Macular Edema and Diabetic Retinopathy First and only prefilled syringe treatment option FDA-approved to ...
The Adapt Oculus trial is unique in that it includes a patient population often overlooked in clinical trials, patients ...
The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...
Washington, DC -- Cracks in the tips of pre-filled plastic syringes used to administer a seizure-control medication may prevent epileptics from getting the full dose they need, health officials warned ...
Since Roche gained approval for its eye disease medication Vabysmo in 2022, it has stormed a market dominated by Regeneron and Bayer’s Eylea. Friday, Roche took another step in its advancement of the ...
UCB, a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system ...
SCHAUMBURG, Ill., Nov. 29 Sagent Pharmaceuticals, Inc., aprivately-held specialty pharmaceutical company today announced that it haslaunched a full-line of prefilled, ready-to-use, 6 mg and 12 mg ...
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results